A single dose of an experimental drug has been found to reduce the risk of genetic heart disease by at least 94 per cent.

Urcosimod in Phase 2 clinical trial for Neuropathic Corneal Pain shown to have Long-Term StabilityUrcosimod stable in single-use ampoules for ...

Lepodisiran, an experimental drug by Eli Lilly, reduces the risk of genetic heart disease by 94%. The drug significantly ...

You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events (including everything from Summerfest to the Milwaukee Film Festival), access ...

WACC (Weighted Average Cost of Capital): 11.05%, coming from 11.5% cost of equity (about 11% I use for a no-moat stock, but I ...

Having a pill stuck in the throat can be irritating or even dangerous, but it is important to stay calm and find a solution. What to do depends on whether the person is conscious and can breathe ...

CTIM-76 first patient dosed in January 2025Cash and cash equivalents of $94.4 million as of December 31, 2024Company expects its cash and cash ...

Keep it Clean. Avoid obscene, hateful, vulgar, lewd, racist or sexually-oriented language. PLEASE TURN OFF YOUR CAPS LOCK. Don't Threaten. Threats of harming another person will not be tolerated ...

“These alarming findings underscore the urgent need for harm reduction strategies, including permanent pill testing services.” Dr Yim said pill testing allowed individuals to verify the ...

The state’s peak medical body is calling for permanent pill testing following the discovery of extremely potent synthetic opioids in wastewater. “AMA Queensland is deeply concerned by the ...

? Type B Meeting Discussion to Accelerate XRx-026 for Gout to NDA ? CALGARY, Alberta, March 19, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | ...